Advanced Search

 

Study ID Status Title Patient Level Data
116952 Completed WEUSKOP6416: Evaluating serious pneumonia in subjects with Chronic Obstructive Pulmonary Disease (COPD) to inform risk minimization: A Retrospective Observational Study
116953 Active, not recruiting Special Drug Use Investigation of BOTOX for Axillary Hyperhidrosis
116954 Completed Inflammatory responsiveness of peripheral blood mononuclear cell (PBMC) and sputum cells taken from Japanese patients with chronic obstructive pulmonary disease (COPD), smoking controls and non-smoking controls
116958 Completed A randomized, double blind, placebo-controlled study to investigate the safety, pharmacodynamics and effect on allergic reactivity of repeat intranasal administration of the TLR7 agonist GSK2245035 in subjects with respiratory allergies
116960 Completed DB2116960: A Randomized, Double-Dummy, Parallel Group, Multicenter Trial Comparing the Efficacy and Safety of UMEC/VI (a fixed combination of Umeclidinium and Vilanterol) With Tiotropium In Subjects with COPD Who Continue To Have Symptoms on Tiotropium Study Listed on ClinicalStudyDataRequest.com
116961 Completed Study DB2116961, A Multicentre, Randomised, Blinded, Parallel Group Study to Compare UMEC/VI (Umeclidinium/Vilanterol) in a Fixed Dose Combination With Indacaterol Plus Tiotropium in Symptomatic Subjects With Moderate to Very Severe COPD Study Listed on ClinicalStudyDataRequest.com
116961 Completed Study DB2116961, A Multicentre, Randomised, Blinded, Parallel Group Study to Compare UMEC/VI (Umeclidinium/Vilanterol) in a Fixed Dose Combination With Indacaterol Plus Tiotropium in Symptomatic Subjects With Moderate to Very Severe COPD Study Listed on ClinicalStudyDataRequest.com
116961 Completed Study DB2116961, A Multicentre, Randomised, Blinded, Parallel Group Study to Compare UMEC/VI (Umeclidinium/Vilanterol) in a Fixed Dose Combination With Indacaterol Plus Tiotropium in Symptomatic Subjects With Moderate to Very Severe COPD Study Listed on ClinicalStudyDataRequest.com
116963 Completed PGx6304: Detailed evaluation of potential role of genetic variation within GLCCI1 and its influence on steroid response
116968 Active, Not Recruiting Administrative Database Study on the Impact of Adherence to Drug Therapy in COPD Patients Treated with Tiotropium as Monotherapy or Co-Administered with ADVAIR in Quebec
116969 Completed An observer-blind study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ Respiratory Syncytial Virus (RSV) investigational vaccine (GSK3003891A) in healthy men
116973 Completed A Randomized, Single-Blind, Dose Escalation, First Time in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of GSK2878175 in Healthy Adults
116974 Completed A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared with Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
116975 Completed Population Meta-Pharmacokinetic Analysis of umeclidinium bromide/vilanterol from two Phase III studies (DB2113361, DB2113373) in Adults with Chronic Pulmonary Obstructive Disease (COPD)
116976 Completed A Randomized, Single Blind, Dose Escalation, Placebo-Controlled Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects with Chronic Hepatitis C.
116977 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparations of Alprazolam 0.5 mg Alprazolam (Zamoprax GlaxoSmithKline México, S.A. de C.V. vs. Tafil 0.5mg, Pharmacia &Upjohn, S.A. de C.V.) in fasting healthy volunteers
116980 Completed PGx: Study of GSK2336805 in HAI115519, genotyping and phenotyping of HCV viral RNA from a Phase II study using 4 weeks of GSK2336805 in combination with pegylated interferon and ribavirin
116981 Completed Open, two periods, two treatments, two sequences, cross-over, randomized trial with single dosageof two oral preparations containing 2 mg of Alprazolam (Zamoprax GlaxoSmithKline México, S.A. de C.V. vs. Tafil 2.0 mg, Pharmacia &Upjohn, S.A. de C.V.) in fasting healthy volunteers
116984 Completed Bioequivalence study of an Amoxicillin-Clavulanic Acid Suspension preparation. Cross-over, randomized, single dose, two treatments, two periods and two sequences trial in fasting conditions
116987 Completed A study to evaluate the pharmacokinetics, safety and tolerability, immunogenicity, and pharmacodynamics of GSK2800528 in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
116990 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparation of Cephalexin 125 mg/ 5 ml (Ceporex® GlaxoSmithKline México, S.A. de C.V. vs. Keflex®, Eli Lilly y Compañía de México, S.A. de C.V.) in fasting healthy volunteers
116991 Terminated A Study ROP116991, Clinical Evaluation of 18 to 24mg/day Ropinirole CR for Parkinson’s disease.
116995 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparation of Cephalexin 250 mg/5mL (Ceporex®, GlaxoSmithKline México, S.A. de C.V. vs. Keflex® , Eli Lilly y Compañía de México, S.A. de C.V.) in fasting healthy volunteers
116999 Completed Open, two periods, two treatments, two sequences, cross-over, randomized study with single dosage of two oral preparations containing 1 g of Cephalexin (GlaxoSmithKline México, S.A. de C.V. vs. Keflex® 1g, Eli Lilly y Compañía de México, S.A. de C.V.) in fasting healthy volunteers.
117002 Completed The Clinical and Economic Benefit of Early Avodart Use vs Early Finasteride Use

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.